• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RUNX1-ETO 靶基因 RASSF2 抑制 t(8;21)AML 的发展并调节 Rac GTP 酶信号转导。

The RUNX1-ETO target gene RASSF2 suppresses t(8;21) AML development and regulates Rac GTPase signaling.

机构信息

Moores Cancer Center, University of California San Diego, La Jolla, CA, 92093, USA.

Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA, 92093, USA.

出版信息

Blood Cancer J. 2020 Feb 6;10(2):16. doi: 10.1038/s41408-020-0282-9.

DOI:10.1038/s41408-020-0282-9
PMID:32029705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7005177/
Abstract

Large-scale chromosomal translocations are frequent oncogenic drivers in acute myeloid leukemia (AML). These translocations often occur in critical transcriptional/epigenetic regulators and contribute to malignant cell growth through alteration of normal gene expression. Despite this knowledge, the specific gene expression alterations that contribute to the development of leukemia remain incompletely understood. Here, through characterization of transcriptional regulation by the RUNX1-ETO fusion protein, we have identified Ras-association domain family member 2 (RASSF2) as a critical gene that is aberrantly transcriptionally repressed in t(8;21)-associated AML. Re-expression of RASSF2 specifically inhibits t(8;21) AML development in multiple models. Through biochemical and functional studies, we demonstrate RASSF2-mediated functions to be dependent on interaction with Hippo kinases, MST1 and MST2, but independent of canonical Hippo pathway signaling. Using proximity-based biotin labeling we define the RASSF2-proximal proteome in leukemia cells and reveal association with Rac GTPase-related proteins, including an interaction with the guanine nucleotide exchange factor, DOCK2. Importantly, RASSF2 knockdown impairs Rac GTPase activation, and RASSF2 expression is broadly correlated with Rac-mediated signal transduction in AML patients. Together, these data reveal a previously unappreciated mechanistic link between RASSF2, Hippo kinases, and Rac activity with potentially broad functional consequences in leukemia.

摘要

大规模染色体易位是急性髓细胞白血病(AML)中频繁的致癌驱动因素。这些易位通常发生在关键的转录/表观遗传调节剂中,并通过改变正常基因表达导致恶性细胞生长。尽管有了这些知识,但导致白血病发展的确切基因表达改变仍不完全清楚。在这里,通过 RUNX1-ETO 融合蛋白的转录调控特征分析,我们确定 Ras 相关结构域家族成员 2(RASSF2)是一种关键基因,在 t(8;21)相关 AML 中异常转录抑制。RASSF2 的重新表达特异性抑制多种模型中的 t(8;21)AML 发展。通过生化和功能研究,我们证明 RASSF2 介导的功能依赖于与 Hippo 激酶 MST1 和 MST2 的相互作用,但独立于经典 Hippo 途径信号。使用基于邻近的生物素标记,我们定义了白血病细胞中 RASSF2 近端蛋白质组,并揭示了与 Rac GTPase 相关蛋白的关联,包括与鸟嘌呤核苷酸交换因子 DOCK2 的相互作用。重要的是,RASSF2 敲低会损害 Rac GTPase 的激活,并且 RASSF2 的表达与 AML 患者中的 Rac 介导的信号转导广泛相关。总之,这些数据揭示了 RASSF2、Hippo 激酶和 Rac 活性之间以前未被认识的机制联系,在白血病中具有潜在的广泛功能后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/6edf4e23aed8/41408_2020_282_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/926849034c79/41408_2020_282_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/3f01b9586c98/41408_2020_282_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/701ff40d0d3c/41408_2020_282_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/515651f4e6e3/41408_2020_282_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/3bf921925a72/41408_2020_282_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/59356ed0abc9/41408_2020_282_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/6edf4e23aed8/41408_2020_282_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/926849034c79/41408_2020_282_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/3f01b9586c98/41408_2020_282_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/701ff40d0d3c/41408_2020_282_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/515651f4e6e3/41408_2020_282_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/3bf921925a72/41408_2020_282_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/59356ed0abc9/41408_2020_282_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f63/7005177/6edf4e23aed8/41408_2020_282_Fig7_HTML.jpg

相似文献

1
The RUNX1-ETO target gene RASSF2 suppresses t(8;21) AML development and regulates Rac GTPase signaling.RUNX1-ETO 靶基因 RASSF2 抑制 t(8;21)AML 的发展并调节 Rac GTP 酶信号转导。
Blood Cancer J. 2020 Feb 6;10(2):16. doi: 10.1038/s41408-020-0282-9.
2
Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling.血小板生成素/MPL 通过 PI3K/AKT 信号参与启动和维持 RUNX1-ETO 急性髓系白血病。
Blood. 2012 Jul 26;120(4):868-79. doi: 10.1182/blood-2012-03-414649. Epub 2012 May 21.
3
RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.RUNX1-ETO 缺失导致 t(8;21) AML 中增强子-启动子相互作用发生 C/EBPα 和 AP-1 介导的改变。
Cell Rep. 2019 Sep 17;28(12):3022-3031.e7. doi: 10.1016/j.celrep.2019.08.040.
4
Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia.分泌卷曲相关蛋白 1 是急性髓细胞白血病中 t(8;21)融合蛋白的转录抑制靶标。
Blood. 2011 Dec 15;118(25):6638-48. doi: 10.1182/blood-2011-05-354712. Epub 2011 Oct 26.
5
Negative effects of GM-CSF signaling in a murine model of t(8;21)-induced leukemia.GM-CSF 信号在 t(8;21)-诱导白血病小鼠模型中的负性作用。
Blood. 2012 Mar 29;119(13):3155-63. doi: 10.1182/blood-2011-04-350694. Epub 2012 Jan 5.
6
Epigenetic regulation of tumor suppressors in t(8:21)-containing AML.含t(8:21)的急性髓系白血病中肿瘤抑制因子的表观遗传调控
Ann Hematol. 2004 Jun;83(6):329-30. doi: 10.1007/s00277-003-0841-8. Epub 2004 Mar 30.
7
Glucocorticoids Inhibit Oncogenic RUNX1-ETO in Acute Myeloid Leukemia with Chromosome Translocation t(8;21).糖皮质激素抑制伴有染色体易位 t(8;21)的急性髓系白血病中的致癌 RUNX1-ETO。
Theranostics. 2018 Mar 8;8(8):2189-2201. doi: 10.7150/thno.22800. eCollection 2018.
8
UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.UBASH3B/Sts-1-CBL轴调节由AML1-ETO诱导的人类白血病前期的髓系增殖。
Leukemia. 2016 Mar;30(3):728-39. doi: 10.1038/leu.2015.275. Epub 2015 Oct 9.
9
Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.条件性AML1-ETO癌基因的表达绕过胚胎致死性,建立了人类t(8;21)急性髓系白血病的小鼠模型。
Cancer Cell. 2002 Feb;1(1):63-74. doi: 10.1016/s1535-6108(02)00016-8.
10
The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.在t(8;21)髓系白血病中,髓系主要调节转录因子PU.1被AML1-ETO失活。
Blood. 2003 Jan 1;101(1):270-7. doi: 10.1182/blood-2002-04-1288. Epub 2002 Aug 29.

引用本文的文献

1
GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia.GATA2将急性髓系白血病的干性与化疗耐药性联系起来。
Blood. 2025 May 8;145(19):2179-2195. doi: 10.1182/blood.2024025761.
2
Insights from DOCK2 in cell function and pathophysiology.DOCK2在细胞功能和病理生理学中的见解。
Front Mol Biosci. 2022 Sep 29;9:997659. doi: 10.3389/fmolb.2022.997659. eCollection 2022.
3
Regulation of RASSF by non-coding RNAs in different cancers: RASSFs as masterminds of their own destiny as tumor suppressors and oncogenes.

本文引用的文献

1
Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation.Hippo 激酶缺失通过慢性固有免疫激活导致 del(20q) 血液系统恶性肿瘤。
Blood. 2019 Nov 14;134(20):1730-1744. doi: 10.1182/blood.2019000170.
2
The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.致癌性 Ras 的功能近端蛋白质组包括 mTORC2。
Mol Cell. 2019 Feb 21;73(4):830-844.e12. doi: 10.1016/j.molcel.2018.12.001. Epub 2019 Jan 10.
3
Hippo Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity.
不同癌症中非编码RNA对RASSF的调控:RASSF作为肿瘤抑制因子和癌基因,决定自身命运的主导因素
Noncoding RNA Res. 2022 May 13;7(2):123-131. doi: 10.1016/j.ncrna.2022.04.001. eCollection 2022 Jun.
4
[Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia].[t(8;21)急性髓系白血病中N6-甲基腺苷修饰模式的特征]
Nan Fang Yi Ke Da Xue Xue Bao. 2022 May 20;42(5):690-697. doi: 10.12122/j.issn.1673-4254.2022.05.09.
5
KDM4B promotes acute myeloid leukemia associated with AML1-ETO by regulating chromatin accessibility.KDM4B通过调节染色质可及性促进与AML1-ETO相关的急性髓系白血病。
FASEB Bioadv. 2021 Sep 12;3(12):1020-1033. doi: 10.1096/fba.2021-00030. eCollection 2021 Dec.
6
AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms.AML1/ETO 及其作为通过表观遗传机制调节基因转录的功能。
Oncogene. 2021 Sep;40(38):5665-5676. doi: 10.1038/s41388-021-01952-w. Epub 2021 Jul 30.
7
The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AML.与 AML 预后相关的基因共表达模块的景观。
J Transl Med. 2021 May 29;19(1):228. doi: 10.1186/s12967-021-02914-2.
8
MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3'UTR.微小RNA let-7b通过靶向t(8;21)急性髓系白血病中AML1-ETO致癌基因的3'非翻译区来下调其表达。
Exp Hematol Oncol. 2021 Feb 2;10(1):8. doi: 10.1186/s40164-021-00204-7.
9
t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming.t(8;21)急性髓系白血病作为在基因调控和染色质编程水平上理解白血病发生机制的范例
Cells. 2020 Dec 13;9(12):2681. doi: 10.3390/cells9122681.
Hippo 激酶 Mst1 和 Mst2 感知并放大调节性 T 细胞中的 IL-2R-STAT5 信号,以建立稳定的调节活性。
Immunity. 2018 Nov 20;49(5):899-914.e6. doi: 10.1016/j.immuni.2018.10.010. Epub 2018 Nov 6.
4
Functional genomic landscape of acute myeloid leukaemia.急性髓系白血病的功能基因组图谱。
Nature. 2018 Oct;562(7728):526-531. doi: 10.1038/s41586-018-0623-z. Epub 2018 Oct 17.
5
The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.致癌转录因子 RUNX1/ETO 通过破坏细胞周期调控驱动白血病转化。
Cancer Cell. 2018 Oct 8;34(4):626-642.e8. doi: 10.1016/j.ccell.2018.08.015.
6
RASSF1A Deficiency Enhances RAS-Driven Lung Tumorigenesis.RASSF1A 缺失增强 RAS 驱动的肺肿瘤发生。
Cancer Res. 2018 May 15;78(10):2614-2623. doi: 10.1158/0008-5472.CAN-17-2466. Epub 2018 May 7.
7
Tumor suppressor C-RASSF proteins.肿瘤抑制因子 C-RASSF 蛋白。
Cell Mol Life Sci. 2018 May;75(10):1773-1787. doi: 10.1007/s00018-018-2756-5. Epub 2018 Jan 20.
8
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.弥漫性大B细胞淋巴瘤的遗传和功能驱动因素
Cell. 2017 Oct 5;171(2):481-494.e15. doi: 10.1016/j.cell.2017.09.027.
9
Transcriptional Addiction in Cancer.癌症中的转录成瘾
Cell. 2017 Feb 9;168(4):629-643. doi: 10.1016/j.cell.2016.12.013.
10
The genomic landscape of core-binding factor acute myeloid leukemias.核心结合因子急性髓系白血病的基因组格局
Nat Genet. 2016 Dec;48(12):1551-1556. doi: 10.1038/ng.3709. Epub 2016 Oct 31.